Latest News for: Takeda Pharmaceutical

Edit

Takeda Announces the Publication of its Annual Report on Form 20-F for FY2025 (Takeda Pharmaceutical Co Ltd)

Public Technologies 17 Jun 2026
OSAKA, Japan, June 17, 2026 - Takeda (TSE.4502/NYSE.TAK) today announced that it has filed its Annual Report on Form 20-F for the fiscal year ended March 31, 2026 (the "Annual Report") with the U.S ... About Takeda ... Takeda Pharmaceutical Co.
Edit

Iran Notice (Form IRANNOTICE) (Takeda Pharmaceutical Co Ltd)

Public Technologies 17 Jun 2026
Takeda Pharmaceutical Company Limited ... Takeda Pharmaceutical Co.
Edit

Annual Report for Fiscal Year Ending March 31, 2026 (Form 20-F) (Takeda Pharmaceutical Co Ltd)

Public Technologies 17 Jun 2026
•During the fiscal year ended March 31, 2025, Takeda decided to enter into discussions with Teva Pharmaceutical Industries Ltd ... Takeda also encourages investors to review the ... Takeda Pharmaceutical Co.
Edit

Notice Concerning Issuance of New Shares and Disposal of Treasury Shares under the Long-Term Incentive Plan for Company Group Employees Outside of Japan (Form 6-K) (Takeda Pharmaceutical Co Ltd)

Public Technologies 09 Jun 2026
... oral presentation, any question and answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited ("Takeda") regarding this press release.
Edit

Notice Concerning Issuance of New Shares and Disposal of Treasury Shares under the Long-Term Incentive Plan for Company Group Employees Outside of Japan (Takeda Pharmaceutical Co Ltd)

Public Technologies 09 Jun 2026
... oral presentation, any question and answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited ("Takeda") regarding this press release.
Edit

Quarterly Highlights InfographicQuarterly Highlights InfographicDownload Quarterly Highlights Infographic (FY25Q4 EN Takeda Infographic 0513) (Takeda Pharmaceutical Co Ltd)

Public Technologies 05 Jun 2026
). The text version of this document is not available ... Takeda Pharmaceutical Co.
Edit

Takeda Updates FY2025 Financial Results Based on Impact of AMITIZA® Antitrust Verdict (Takeda Pharmaceutical Co Ltd)

Public Technologies 05 Jun 2026
) Revision Made to Reported Results for FY2025 - No Changes to Takeda's Core Financial Results for FY2025 No Changes to FY2026 Forecast and Management Guidance Takeda Will Vigorously Pursue Post-trial Motions and an Appeal ... Takeda Pharmaceutical Co.
Edit

TAKEDA PHARMACEUTICAL COMPANY LIMITED (Form 6-K) (Takeda Pharmaceutical Co Ltd)

Public Technologies 05 Jun 2026
Takeda Pharmaceutical Company Limited ... Takeda recently announced that, on May 18, 2026 (U.S ... Following the jury verdict, Takeda has been assessing its impact on the consolidated financial statements ... Takeda Pharmaceutical Co.
Edit

Revision of FY2025 Consolidated Financial Statements (Takeda Pharmaceutical Co Ltd)

Public Technologies 05 Jun 2026
). The text version of this document is not available ... Takeda Pharmaceutical Co.
Edit

PresentationPresentationDownload Presentation (qr2025 q4 p01 en 20260513) (Takeda Pharmaceutical Co Ltd)

Public Technologies 05 Jun 2026
). The text version of this document is not available ... Takeda Pharmaceutical Co.
Edit

FINANCIAL APPENDIX (Form 6-K) (Takeda Pharmaceutical Co Ltd)

Public Technologies 05 Jun 2026
... the fact that Takeda's subordinated bonds are not eligible for equity treatment under IFRS, although Takeda believes this adjustment to be reasonable and useful to investors ... Takeda Pharmaceutical Co.
Edit

Notice Concerning Withdrawal of Shelf Registration Statement and Filing of New Shelf Registration Statement in Japan (Takeda Pharmaceutical Co Ltd)

Public Technologies 01 Jun 2026
... any oral presentation, any question and answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited ("Takeda") regarding this release.
Edit

Notice Concerning Withdrawal of Shelf Registration Statement and Filing of New Shelf Registration Statement in Japan (Form 6-K) (Takeda Pharmaceutical Co Ltd)

Public Technologies 01 Jun 2026
... oral presentation, any question and answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited ("Takeda") regarding this press release.
Edit

TAKEDA'S EXECUTIVE COMPENSATION OVERVIEW (Form 6-K) (Takeda Pharmaceutical Co Ltd)

Public Technologies 26 May 2026
). The text version of this document is not available ... Takeda Pharmaceutical Co.
Edit

Planned Revision of Consolidated Financial Statements Related to a Subsequent Event (Takeda Pharmaceutical Co Ltd)

Public Technologies 26 May 2026
). The text version of this document is not available ... Takeda Pharmaceutical Co.

Article Search

tools
×
×
×
×